13109 Phosphorylation state of Myristoylated Alanine-Rich C-Kinase Substrate Effector Domain mimetics determines its cytotoxicity in glioblastoma and macrophage model
ABSTRACT IMPACT: This study provides insight into how MED2 impacts the immune cells surrounding glioblastoma that help it to grow and spread; having a more complete understanding of how MED2 works will help us better develop therapies that may one day enter the clinic to improve patient outcomes in...
Main Authors: | Hasan Alrefai, Nicholas J. Eustace, Joshua C. Anderson, Patricia H. Hicks, Peter H. King, Christopher D. Willey |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-03-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866121004039/type/journal_article |
Similar Items
-
Small Organic Compounds Mimicking the Effector Domain of Myristoylated Alanine-Rich C-Kinase Substrate Stimulate Female-Specific Neurite Outgrowth
by: Monica Tschang, et al.
Published: (2023-09-01) -
Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies
by: Deepak Narayanan Iyer, et al.
Published: (2021-05-01) -
Myristoylated, alanine-rich C-kinase substrate (MARCKS) regulates toll-like receptor 4 signaling in macrophages
by: Jiraphorn Issara-Amphorn, et al.
Published: (2023-11-01) -
Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brain.
by: Hiroaki Okuda, et al.
Published: (2010-01-01) -
A myristoylated alanine-rich C-kinase substrate (MARCKS) inhibitor peptide attenuates neutrophil outside-in β2-integrin activation and signaling
by: Haleigh Conley, et al.
Published: (2023-12-01)